The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous ...

Hypoglycemia or low blood sugar level is quite common in diabetics. But it does not mean people without diabetes can't ...

Advertisement management junior Yashika Ramchandani created T100 Pro Bars, power bars geared towards people with diabetes and ...

“Continuous glucose monitors with low-glucose alerts can potentially reduce the risk of hypoglycemia for insulin-treated ...

The following is a summary of “Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Public health advice on the safe consumption of glycerol-containing slush ice drinks, also known as slushees, may need ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Ramchandani immediately began researching ways to help, and soon realized there were very few food options for those suffering from hypoglycemia, a condition that commonly accompanies diabetes.

A Japanese study has found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics when their blood sugar levels drop, can potentially make diabetic ...